Singular Health Group Ltd

SHG.ASX

Health Care

Sale and development of medical imaging and visualisation software and technology.

Market Data

Price

$0.200

+0.0%
Market Cap

$61.8M

P/E Ratio

-100000.0x

EPS

$-0.023

Div. Yield

0.00%

52-Week Change

-0.3%

Latest Earnings

Appendix 4D Half Yearly Report and Accounts

24 February 2026

Revenue
$0.48
+345.0% YoY
NPAT
-$2.97
+55.0% YoY
EPS
$-0.01

Singular Health Group reported strong revenue growth of 345% to $479k for H1 FY2026, driven by deployment of 3DICOM licenses through the PNS agreement. However, the company posted a larger net loss of $3.0M compared to $1.9M in the prior period, primarily due to $1.0M in share-based payment expenses and increased personnel costs from strategic hires in the USA and Singapore. Following the period end, the company achieved FDA 510(k) clearance for its 3DICOM MD® Cloud platform in January 2026, expanding its addressable market to an estimated US$16.5B. Key points: Strong revenue growth of 345% to $479k driven by 3DICOM license deployments; Successful deployment of 250 3DICOM MD® licenses across PNS Primary Care Provider network with additional 500 licenses scheduled for Q1 CY2026; FDA 510(k) clearance received for 3DICOM MD® Cloud in January 2026, expanding addressable market to estimated US$16.5B

Recent Announcements

24 Feb 2026 Actual Results Neutral

Appendix 4D Half Yearly Report and Accounts

Singular Health Group reported strong revenue growth of 345% to $479k for H1 FY2026, driven by deployment of 3DICOM licenses through the PNS agreement. However, the company posted a larger net loss of $3.0M compared to $1.9M in the prior period, primarily due to $1.0M in share-based payment expenses and increased personnel costs from strategic hires in the USA and Singapore. Following the period end, the company achieved FDA 510(k) clearance for its 3DICOM MD® Cloud platform in January 2026, expanding its addressable market to an estimated US$16.5B. Key points: Strong revenue growth of 345% to $479k driven by 3DICOM license deployments; Successful deployment of 250 3DICOM MD® licenses across PNS Primary Care Provider network with additional 500 licenses scheduled for Q1 CY2026; FDA 510(k) clearance received for 3DICOM MD® Cloud in January 2026, expanding addressable market to estimated US$16.5B

Get real-time alerts for SHG

Receive AI-powered earnings summaries and instant notifications when Singular Health Group Ltd releases results.

Register Free